Literatur
Barbui T et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J. 2018;8(2):15
Cario H et al. Clinical and hematological presentation of children and adolescents with polycythemia vera. Ann Hematol. 2009;88(8):713-9
Cario H et al. Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera. Br J Haematol. 2008;142(4):622-6
Ianotto JC et al. Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review. Haematologica. 2019;104(8):1580-8
Putti MC et al. Essential thrombocythemia in children and adolescents. Cancers. 2021;13(23):6147
Cario H et al. Erythrocytosis in children and adolescents-classification, characterization, and consensus recommendations for the diagnostic approach. Pediatr Blood Cancer. 2013;60(11):1734-8
Tuschl K et al. Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am J Hum Genet. 2012;90(3):457-66
Stockklausner C et al. Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management. Ann Hematol. 2021;100(7):1647-65
Petrides PE et al. Onkopedia-Leitlinie essentielle Thrombozythaemie. www.onkopedia.com
Lengfelder E et al. Onkopedia-Leitlinie Polycythaemia vera. www.onkopedia.com
Gruppo Italiano Studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 Years. Ann Intern Med. 1995;123(9):656-64
Rungjirajittranon T et al. A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms. BMC cancer. 2019;19(1):184
Kucine N et al. Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia. Pediatr Blood Cancer. 2021;68(3):e28888
Stoops K, Kuril S. Ruxolitinib in a child with JAK2 exon 12 mutant polycythemia vera. J Ped Hematol Oncol. 2022; doi: 10.1097/MPH.0000000000002549
Barbui T. How to manage children and young adults with myeloproliferative neoplasms. Leukemia. 2012;26(7):1452-7
Aydogan T et al. Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets. 2006;17(5):328-31
Buss DH et al. Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am J Med. 1994;96(3):247-53
Simanek R et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Hemost. 2010;8(1):114-20
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Der Autor war als Referent und Berater für Novartis, Chiesi, BMS/Celgene, BluebirdBio und Vertex tätig. Er erklärt, dass dies keinen Einfluss auf die Inhalte des Beitrags hatte.
Rights and permissions
About this article
Cite this article
Cario, H. Polycythaemia vera und essenzielle Thrombozythämie. Pädiatrie 34, 44–49 (2022). https://doi.org/10.1007/s15014-022-4759-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15014-022-4759-9